Publications
- (1) Balius, T.E.; Rizzo, R. C. Quantitative Prediction of Fold Resistance for Inhibitors of EGFR. Biochemistry, 2009, 48 (35), 8435-8448
doi:10.1021/bi900729a
PMID: 19627157
- (2) Owonikoko T. K.; Ramalingam S. S.; Kanterewicz B.; Balius T. E.; Belani C. P.; Hershberger P. A. Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells. International Journal of Cancer 2010 126, 743-755
doi:10.1002/ijc.24759
PMID: 19621389
- (3) McGillick, B. E.; Balius, T.E.; Mukherjee, S.; Rizzo, R. C. Origins of Resistance to the HIVgp41 Viral Entry Inhibitor T20. Biochemistry, 2010, 49 (17), 3575-3592
doi:10.1021/bi901915g
PMID: 20230061
- (4) Mukherjee S.; Balius, T.E.; Rizzo, R. C. Docking Validation Resources: Protein Family and Ligand Flexibility Experiments. J. Chem. Inf. Model., 2010, 50 (11), 1986-2000
doi:10.1021/ci1001982
PMID: 21033739
- (5) Balius, T.E.; Mukherjee S.; Rizzo, R. C. Implementation and Evaluation of
a Docking-Rescoring Method using Molecular Footprint Comparisons. J. Comput. Ch
em., 2011, 32(10), 2273.2289
doi:10.1002/jcc.21814
PMID: 21541962
- (6) Brozell, S. R.; Mukherjee, S.; Balius, T. E.; Roe, D. R.; Case, D. A.; Rizzo, R. C. Evaluation of DOCK 6 as a Pose Generation and Database Enrichment Tool. J. Comput-Aided Mol Des, 2012, in press
doi:10.1007/s10822-012-9565-y
modified: 2012/04/02